Shenghong Zhang

5.2k total citations · 1 hit paper
152 papers, 3.8k citations indexed

About

Shenghong Zhang is a scholar working on Genetics, Epidemiology and Molecular Biology. According to data from OpenAlex, Shenghong Zhang has authored 152 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Genetics, 48 papers in Epidemiology and 43 papers in Molecular Biology. Recurrent topics in Shenghong Zhang's work include Inflammatory Bowel Disease (70 papers), Microscopic Colitis (33 papers) and Helicobacter pylori-related gastroenterology studies (13 papers). Shenghong Zhang is often cited by papers focused on Inflammatory Bowel Disease (70 papers), Microscopic Colitis (33 papers) and Helicobacter pylori-related gastroenterology studies (13 papers). Shenghong Zhang collaborates with scholars based in China, Israel and United States. Shenghong Zhang's co-authors include Minhu Chen, Yao He, Minhu Chen, Li Li, Zhirong Zeng, Yun Qiu, Ren Mao, Yi Cui, Zhirong Zeng and Bihui Zhong and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Shenghong Zhang

147 papers receiving 3.7k citations

Hit Papers

Oxidative stress gene expression, DNA methylation, and gu... 2023 2026 2024 2025 2023 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shenghong Zhang China 34 1.5k 1.0k 891 703 694 152 3.8k
Akio Ido Japan 38 1.0k 0.7× 528 0.5× 929 1.0× 1.7k 2.4× 276 0.4× 243 4.4k
Brian K. Dieckgraefe United States 33 1.4k 0.9× 914 0.9× 620 0.7× 572 0.8× 352 0.5× 64 3.4k
Susumu Satomi Japan 39 1.5k 1.0× 796 0.8× 2.8k 3.2× 624 0.9× 333 0.5× 215 5.7k
Gwenny M. Fuhler Netherlands 31 1.4k 0.9× 348 0.3× 516 0.6× 413 0.6× 301 0.4× 132 3.1k
Hua Yang China 37 1.9k 1.3× 328 0.3× 674 0.8× 323 0.5× 685 1.0× 179 4.1k
Xuchen Zhang United States 35 2.0k 1.3× 315 0.3× 745 0.8× 1.1k 1.6× 437 0.6× 191 4.8k
Dai H. Chung United States 40 1.9k 1.3× 305 0.3× 868 1.0× 469 0.7× 654 0.9× 155 4.0k
Janice Russell United States 39 1.4k 1.0× 395 0.4× 702 0.8× 518 0.7× 231 0.3× 109 4.2k
Gholamreza Azizi Iran 43 1.5k 1.0× 939 0.9× 374 0.4× 546 0.8× 525 0.8× 217 6.0k
Toshiharu Ishii Japan 49 1.6k 1.0× 669 0.7× 1.5k 1.7× 331 0.5× 494 0.7× 155 5.6k

Countries citing papers authored by Shenghong Zhang

Since Specialization
Citations

This map shows the geographic impact of Shenghong Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenghong Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenghong Zhang more than expected).

Fields of papers citing papers by Shenghong Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shenghong Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenghong Zhang. The network helps show where Shenghong Zhang may publish in the future.

Co-authorship network of co-authors of Shenghong Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Shenghong Zhang. A scholar is included among the top collaborators of Shenghong Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shenghong Zhang. Shenghong Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Li, Li, et al.. (2025). Magnetic resonance enterography for predicting poor prognosis in Crohn’s disease: a systematic review with meta-analysis. Therapeutic Advances in Gastroenterology. 18. 1128569293–1128569293.
3.
Wang, Ying, Jing Han, Guang Yang, et al.. (2024). Therapeutic potential of the secreted Kazal-type serine protease inhibitor SPINK4 in colitis. Nature Communications. 15(1). 5874–5874. 5 indexed citations
4.
Li, Chao, et al.. (2024). Predictors for colectomy in patients with acute severe ulcerative colitis: a systematic review and meta-analysis. BMJ Open Gastroenterology. 11(1). e001587–e001587. 1 indexed citations
5.
Li, Chao, Kang Chao, Zhirong Zeng, et al.. (2023). Neutrophil-to-lymphocyte ratio for predicting postoperative recurrence in Crohn’s disease patients with isolated anastomotic lesions. Therapeutic Advances in Gastroenterology. 16. 1108348105–1108348105. 3 indexed citations
6.
Zhang, Xi, et al.. (2023). Fecal lactoferrin early predicts long‐term outcomes in ulcerative colitis: A post‐hoc analysis of the UNIFI and PURSUIT trials. United European Gastroenterology Journal. 11(6). 542–550. 4 indexed citations
7.
Xie, Zhuo, Gaoshi Zhou, Jing Han, et al.. (2023). Recent developments on BMPs and their antagonists in inflammatory bowel diseases. Cell Death Discovery. 9(1). 210–210. 13 indexed citations
8.
Li, Xiaoling, Gaoshi Zhou, Zhuo Xie, et al.. (2023). Role of Rho GTPases in inflammatory bowel disease. Cell Death Discovery. 9(1). 24–24. 8 indexed citations
9.
Huang, Yongle, Xi Zhang, Zhirong Zeng, et al.. (2023). Rapidly achieving clinical remission in ulcerative colitis indicates better endoscopic and histological outcomes. United European Gastroenterology Journal. 12(4). 459–468. 2 indexed citations
10.
Zhou, Gaoshi, et al.. (2022). Development and validation of a non-invasive biomarker-based model to identify endoscopic recurrences of Crohn’s disease. Therapeutic Advances in Gastroenterology. 15. 1098272072–1098272072.
11.
Li, Li, Chao Li, Kang Chao, et al.. (2021). Metabolomics facilitate the personalized management in inflammatory bowel disease. Therapeutic Advances in Gastroenterology. 14. 1088247465–1088247465. 11 indexed citations
12.
Xie, Zhuo, Ying Wang, Guang Yang, et al.. (2021). The role of the Hippo pathway in the pathogenesis of inflammatory bowel disease. Cell Death and Disease. 12(1). 79–79. 49 indexed citations
13.
Xie, Zhuo, Gaoshi Zhou, Lihui Lin, et al.. (2021). Emerging roles of the Hedgehog signalling pathway in inflammatory bowel disease. Cell Death Discovery. 7(1). 314–314. 19 indexed citations
14.
Li, Li, Kang Chao, Qian Cao, et al.. (2020). Platelet-to-lymphocyte percentage ratio index: a simple non-invasive index to monitor the endoscopic activity in Crohn’s disease. Therapeutic Advances in Gastroenterology. 13. 3974168306–3974168306. 5 indexed citations
15.
Zhang, Yu, Xiaozhi Li, Yaoting Li, et al.. (2020). DNA Damage-Regulated Autophagy Modulator 1 (DRAM1) Mediates Autophagy and Apoptosis of Intestinal Epithelial Cells in Inflammatory Bowel Disease. Digestive Diseases and Sciences. 66(10). 3375–3390. 24 indexed citations
16.
Lin, Lihui, Gaoshi Zhou, Peng Chen, et al.. (2020). Which long noncoding RNAs and circular RNAs contribute to inflammatory bowel disease?. Cell Death and Disease. 11(6). 456–456. 55 indexed citations
17.
Zhang, Qiushi, et al.. (2019). Clinical outcome of Escherichia coli bloodstream infection in cancer patients with/without biofilm formation: a single-center retrospective study. SHILAP Revista de lepidopterología. 2 indexed citations
18.
Qiu, Yun, Baili Chen, Ren Mao, et al.. (2017). Systematic review with meta-analysis: loss of response and requirement of anti-TNFα dose intensification in Crohn’s disease. Journal of Gastroenterology. 52(5). 535–554. 142 indexed citations
19.
Qiu, Yun, Baili Chen, Ren Mao, et al.. (2015). Endoscopy Assessment at 1-Year Identifies Long-Term Responders to Thiopurines Maintenance Therapy in Patients With Crohn's Disease. Medicine. 94(31). e1204–e1204. 5 indexed citations
20.
Zhang, Shenghong. (2013). Characteristics of Peanut Soil and Improvement Measures in Hong'an County. Hubei nongye kexue. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026